<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
17088-0370-1
</NDCCode>
<PackageDescription>
2.5 mL in 1 VIAL, SINGLE-USE (17088-0370-1)
</PackageDescription>
<NDC11Code>
17088-0370-01
</NDC11Code>
<ProductNDC>
17088-0370
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Basiliximab
</NonProprietaryName>
<DosageFormName>
INJECTION, POWDER, FOR SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
19980512
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Novartis Pharma Stein AG
</LabelerName>
<SubstanceName>
BASILIXIMAB
</SubstanceName>
<StrengthNumber>
10
</StrengthNumber>
<StrengthUnit>
mg/2.5mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2026-03-12
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
12-MAY-98
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>